Speciality Medicines IPO
Speciality Medicines IPO is an SME IPO raising ₹29 Cr at ₹117 – ₹124 a share. It listed on 30 Mar 2026 at ₹124, 0.0% against its issue price of ₹124, and trades at ₹167 today (+34.7% since issue). It was subscribed 2.31× in total.
2.3 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
What happened after it listed
The return since issue is computed from our own daily closes, never from the exchange’s listing-price field — that one is missing for about 47% of listed issues, so it could never carry the headline. It is shown here as its own fact, the debut price, wherever the exchange did publish it.
“Listed at” is the price the share opened at on debut, so the listing gain is what the market paid on day one — not what it pays now, and not the first day’s closing price.
Multi-horizon returns — listing day, one week, one month, three, six and a year — are being built and will appear here.
How its cohort has done
131 SME issues listed in 2026 that we can price today. This is the group this issue belongs to.
Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →
Everything this company files, from here on
A newly listed company starts filing results, orders and board decisions immediately. We summarise each one and send it to your WhatsApp.